Correlation Between Pharvaris and Celldex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Celldex Therapeutics, you can compare the effects of market volatilities on Pharvaris and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Celldex Therapeutics.
Diversification Opportunities for Pharvaris and Celldex Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Pharvaris and Celldex is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Pharvaris i.e., Pharvaris and Celldex Therapeutics go up and down completely randomly.
Pair Corralation between Pharvaris and Celldex Therapeutics
Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Celldex Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 1.36 times less risky than Celldex Therapeutics. The stock trades about -0.35 of its potential returns per unit of risk. The Celldex Therapeutics is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest 2,454 in Celldex Therapeutics on November 27, 2024 and sell it today you would lose (208.00) from holding Celldex Therapeutics or give up 8.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharvaris BV vs. Celldex Therapeutics
Performance |
| Timeline |
| Pharvaris BV |
| Celldex Therapeutics |
Pharvaris and Celldex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and Celldex Therapeutics
The main advantage of trading using opposite Pharvaris and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.| Pharvaris vs. Pmv Pharmaceuticals | Pharvaris vs. MediciNova | Pharvaris vs. PepGen | Pharvaris vs. Molecular Partners AG |
| Celldex Therapeutics vs. Ideaya Biosciences | Celldex Therapeutics vs. AnaptysBio | Celldex Therapeutics vs. MeiraGTx Holdings PLC | Celldex Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |